Abstract
Boron neutron capture therapy (BNCT) is a unique method that can deliver tumor-cell-selective high-linear energy transfer (LET) particle radiotherapy to an extended target area encompassing a microscopic invasion while avoiding radiation damage to the surrounding normal brain tissue. The process of BNCT is based on the nuclear interaction of 10B with thermal neutrons with the release of high LET α and 7Li particles through the boron neutron capture reaction, 10B(n, α) 7Li. The very short path length (<9 μm) of α-particles and 7Li enables high-LET irradiation of tumor cells without undesirable damage to 10B-unloaded normal cells. Eight non-randomized prospective external beam BNCT trials for glioblastoma (GBM) have been performed over 15 years using the two currently available boron drugs and a neutron beam at a nuclear reactor. Four of the 8 studies suggested that the external beam BNCT may improve survival in newly diagnosed GBM. In addition, 4 of the 8 studies were primary phase I trials that demonstrated only modest toxicity. The median time to progression and the median survival time (MST) were 6–12 months and 12–27 months, respectively. The optimization of dosage and boron delivery agents, the combined use of different boron agents, the combination of BNCT with other therapeutic modalities and the development of a hospital-based neutron source have been studied for the improvement of BNCT. The need for more evidence-based data, either through randomized trials or using a prospective case control methodology, is clear from a review of the clinical reports.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barth RF, Coderre JA, Vicente GH, Blue TE (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11:3987–4002
Buatti J, Ryken TC, Smith MC, Sneed P, Suh JH, Mehta M, Olson JJ (2008) Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol 89:313–337
Burian J, Marek M, Rataj J, Flibor S, Rejchrt J, Viererbl L, Sus F, Honova H, Petruzelka L, Prokes K, Tovarys F, Dbaly V, Benes V, Kozler P, Honzatko J, Tomandl I, Mares V, Marek J, Syrucek M (2002) Report on the first patient group of the phase I BNCT trial at the LVR-15 reactor. In: Surewein W, Moss R, Wittig A (eds) Research and development in neutron capture therapy. Monduzzi Editore, Bologna, pp 1107–1112
Busse PM, Harling OK, Palmer MR, Kiger WS III, Kaplan J, Kaplan I, Chuang CF, Goorley JT, Riley KJ, Newton TH, Santa Cruz GA, Lu XQ, Zamenhof RG (2003) A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 62:111–121
Capuani S, Gili T, Bozzali M, Russo S, Porcari P, Cametti C, D’Amore E, Colasanti M, Venturini G, Maraviglia B, Lazzarino G, Pastore FS (2008) L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. Int J Radiat Oncol Biol Phys 72:562–567
Chanana AD, Capala J, Chadha M, Coderre JA, Diaz AZ, Elowitz EH, Iwai J, Joel DD, Liu HB, Ma R, Pendzick N, Peress NS, Shady MS, Slatkin DN, Tyson GW, Wielopolski L (1999) Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies. Neurosurgery 44:1182–1193
Coderre JA, Hopewell JW, Turcottea JC, Rileyc KJ, Binnsc PJ, Kiger WS III, Harling OK (2004) Tolerance of normal human brain to boron neutron capture therapy. Appl Radiat Isot 61:1083–1087
Coderre JA, Turcotte JC, Riley KJ, Binns PJ, Harling OK, Kiger WS III (2003) Boron neutron capture therapy: Cellular targeting of high linear energy transfer radiation. Technol Cancer Res Treat 5:355–375
Diaz AZ (2003) Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician’s point of view. J Neurooncol 62:101–109
Fitzek MM, Thornton AF, Rabinov JD, Lev MH, Pardo FS, Munzenrider JE, Okunieff P, Bussiere M, Braun I, Hochberg FH, Hedley-Whyte ET, Liebsch NJ, Harsh GR 4th (1990) Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 91:251–260
Haginomori S, Miyatake S, Inui T, Kawabata S, Takamai A, Lee K, Takenaka H, Kuroiwa T, Uesugi Y, Kumada H, Ono K (2008) Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report. Head Neck 31:412–418
Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim T (2008) Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Radiother Oncol 88:183–191
Joensuu H, Kankaanranta L, Seppälä T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vähätalo J, Kortesniemi M, Kotiluoto P, Seren T, Karila J, Brander A, Järviluoma E, Ryynänen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jääskeläinen J, Färkkilä M, Savolainen S (2003) Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine. J Neurooncol 62:123–134
Kankaanranta L, Koivunoro H, Kortesniemi M, Välimäki P, Seppälä T, Kotiluoto P, Auterinen I, Kouri M, Savolainen S, Joensuu H (2008) BPA-based BNCT in the treatment of glioblastoma multiforme In: Zonta A, Altieri S, Roveda L, Barth R (eds) A dose escaration study. Proceedings of the 13th international congress of neutron capture therapy. ENEA, p 30
Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Mäkitie A, Seppänen M, Minn H, Kotiluoto P, Auterinen I, Savolainen S, Kouri M, Joensuu H (2007) Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 69:475–482
Kawabata S, Miyatake S, Kuroiwa T, Yokoyama K, Doi A, Iida K, Miyata S, Nonoguchi N, Michiue H, Takahashi M, Inomata T, Imahori Y, Kirihata M, Sakurai Y, Maruhashi A, Kumada H, Ono K (2008) Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res (Tokyo) 50:51–60
Kumada H, Nakamura T, Komeda M, Matsumura A (2009) Development of a new multimodal Monte-Carlo radiotherapy planning system. Appl Radiat Isot 67:118–121
Kumada H, Yamamoto K, Matsumura A, Yamamoto T, Nakagawa Y (2007) Development of JCDS, a computational dosimetry system at JAEA for boron neutron capture therapy. J Phy Conf Ser 74:1–7
Nariai T, Ishiwata K, Kimura Y, Inaji M, Momose T, Yamamoto T, Matsumura A, Ishii K, Ohno K (2009) PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. Appl Radiat Isot 67:S348–S350
Nielsen FH (2009) Micronutrients in parenteral nutrition: boron, silicon, and fluoride. Gastroenterology 137:S55–S60
Nigg DW (2003) Computational dosimetry and treatment planning considerations for neutron capture therapy. J Neurooncol 62:75–86
Sköld K-H, Stenstam B, Diaz AZ, Giusti V, Pellettieri L, Hopewell JW (2009) Boron neutron capture therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f. Acta Neurol Scand. [Epub ahead of print]
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Tanaka M, Ino Y, Nakagawa K, Tago M, Todo T (2005) High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. Lancet Oncol 6:953–960
Wittig A, Hideghety K, Paquis P, Heimans J, Vos M, Goetz C, Haselsberger K, Grochulla F, Moss R, Morrissey J, Bourhis-Martin E, Rassow J, Stecher-Rasmussen F, Turowski B, Westler M, deVris MJ, Fankhauser H, Gabel D, Sauerwein W (2002) Current clinical results of the EORTC-study 11961. In: Surewein W, Moss R, Wittig A (eds) Research and development in neutron capture therapy. Monduzzi Editore, Bologna, pp 1117–1122
Yamamoto T, Nakai K, Kageji T, Kumada H, Endo K, Matsuda M, Shibata Y, Matsumura A (2009) Boron neutron capture therapy for newly diagnosed glioblastoma. Radiother Oncol 91:80–84
Yamamoto T, Nakai K, Matsumura A (2008) Boron neutron capture therapy for glioblastoma. Cancer Lett 262:143–152
Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ (2009) Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. J Neurooncol 95:355–365
Yoshida F, Matsumura A, Shibata Y, Yamamoto T, Nakauchi H, Okumura M, Nose T (2002) Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy. Cancer Lett 187:135–141
Yoshida F, Yamamoto T, Nakai K, Kumada H, Shibata Y, Tsuruta W, Endo K, Tsurubuchi T, Matsumura A (2008) Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model. Cancer Lett 263:253–258
Acknowledgments
This study was supported in part by a Grant-in-Aid for Society Collaboration from the Ministry of Education, Science and Culture of Japan (20390379). We thank Professor Akira Matsumura, Dr. Tadashi Nariai and Dr. Alexander Zaboronok for their kind support in the manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Yamamoto, T., Nakai, K., Kumada, H. (2011). Glioblastoma: Boron Neutron Capture Therapy. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 2. Tumors of the Central Nervous System, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0618-7_24
Download citation
DOI: https://doi.org/10.1007/978-94-007-0618-7_24
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0617-0
Online ISBN: 978-94-007-0618-7
eBook Packages: MedicineMedicine (R0)